MOR logo

MorphoSys AG (MOR) Cash From Financing

Annual CFF

$46.55 M
-$281.87 M-85.83%

December 31, 2023

Summary

Performance

1-Year Change

-85.83%

3-Year Change

-95.51%

5-Year Change

-78.03%

15-Year Change

+402.87%

MOR Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.57 B
MOR annual cash flow from financing activities is currently -97.03% below its historical high of $1.57 billion

3-Year Low

$46.55 M
MOR annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MOR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
MOR next annual earnings announcement has not yet been scheduled

OtherMORcash flowmetrics:

Annual CFI

$16.64 M
MOR annual cash flow from investing activities is $16.64 million

Annual CFO

-$320.28 M
MOR annual cash flow from operations is -$320.28 million

Annual FCF

-$323.39 M
MOR annual free cash flow is -$323.39 million

Annual CAPEX

$3.11 M
MOR annual capital expenditures is $3.11 million

Quarterly CFF

N/A

December 31, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

MOR Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.52 B
MOR quarterly cash flow from financing activities is currently at an all-time high

3-Year Low

-$48.68 M
MOR quarterly cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
MOR previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
MOR next earnings announcement has not yet been scheduled

OtherMORcash flowmetrics:

Quarterly CFI

-
MOR quarterly cash flow from investing activities value is unknown

Quarterly CFO

-
MOR quarterly cash flow from operations value is unknown

Quarterly FCF

-
MOR quarterly free cash flow value is unknown

Quarterly CAPEX

-
MOR quarterly capital expenditures value is unknown

TTM CFF

N/A

December 31, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

MOR TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.91 B
MOR TTM cash flow from financing activities is currently at an all-time high

3-Year Low

-$54.52 M
MOR TTM cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
MOR previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
MOR next earnings announcement has not yet been scheduled

OtherMORcash flowmetrics:

TTM CFI

-
MOR TTM cash flow from investing activities value is unknown

TTM CFO

-
MOR TTM cash flow from operations value is unknown

TTM FCF

-
MOR TTM free cash flow value is unknown

TTM CAPEX

-
MOR TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

MOR Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-85.8%--
3 y3 years-95.5%--
5 y5 years-78.0%--

MOR Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-97.0%at low
5 y5-year-97.0%-99.2%
alltimeall time-97.0%-111.2%

MorphoSys AG Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2023
$46.55 M(-85.8%)
-
-
Jun 2023
-
-$5.84 M(-88.0%)
-$54.52 M(+15.0%)
Mar 2023
-
-$48.68 M(-3884.3%)
-$47.39 M(-103.1%)
Dec 2022
$328.42 M(-79.0%)
-
-
Jun 2022
-
$1.29 M(-91.7%)
$1.55 B(-1.2%)
Mar 2022
-
$15.46 M(+24.3%)
$1.57 B(+0.1%)
Dec 2021
$1.57 B(+51.1%)
$12.44 M(-99.2%)
$1.57 B(-18.2%)
Sep 2021
-
$1.52 B(+7389.0%)
$1.91 B(+340.8%)
Jun 2021
-
$20.29 M(+52.7%)
$434.29 M(-58.6%)
Mar 2021
-
$13.29 M(-96.3%)
$1.05 B(+1.3%)
Dec 2020
$1.04 B(>+9900.0%)
$361.50 M(+821.6%)
$1.04 B(+53.6%)
Sep 2020
-
$39.22 M(-93.8%)
$674.48 M(+5.8%)
Jun 2020
-
$635.31 M(<-9900.0%)
$637.50 M(>+9900.0%)
Dec 2019
$395.50 K(-99.8%)
-$59.80 K(-102.7%)
$395.40 K(-88.8%)
Sep 2019
-
$2.25 M(-372.8%)
$3.54 M(-212.5%)
Jun 2019
-
-$825.90 K(-15.0%)
-$3.15 M(-101.5%)
Mar 2019
-
-$971.80 K(-131.5%)
$210.94 M(-0.5%)
Dec 2018
$211.91 M(+2189.2%)
$3.09 M(-169.6%)
$211.91 M(+0.3%)
Sep 2018
-
-$4.43 M(-102.1%)
$211.24 M(-2.6%)
Jun 2018
-
$213.26 M(>+9900.0%)
$216.79 M(+2241.9%)
Mar 2018
-
$0.00(-100.0%)
$9.26 M(0.0%)
Dec 2017
$9.26 M(-92.4%)
$2.42 M(+116.3%)
$9.26 M(-93.0%)
Sep 2017
-
$1.12 M(-80.5%)
$131.47 M(+0.8%)
Jun 2017
-
$5.73 M(-95.4%)
$130.38 M(+6.7%)
Dec 2016
$122.19 M(-2808.3%)
$124.63 M(>+9900.0%)
$122.19 M(-9045.1%)
Sep 2016
-
$29.80 K(-150.1%)
-$1.37 M(+8.9%)
Jun 2016
-
-$59.50 K(-97.5%)
-$1.25 M(-82.2%)
Mar 2016
-
-$2.41 M(-324.7%)
-$7.03 M(+55.8%)
Dec 2015
-$4.51 M
$1.07 M(+658.2%)
-$4.51 M(+7.7%)
Sep 2015
-
$141.30 K(-102.4%)
-$4.19 M(+14.5%)
Jun 2015
-
-$5.84 M(-5338.5%)
-$3.66 M(-165.0%)
DateAnnualQuarterlyTTM
Mar 2015
-
$111.40 K(-92.0%)
$5.63 M(-208.1%)
Dec 2014
-$5.21 M(-103.0%)
$1.39 M(+107.8%)
-$5.21 M(+15.3%)
Sep 2014
-
$671.10 K(-80.6%)
-$4.52 M(-102.7%)
Jun 2014
-
$3.46 M(-132.2%)
$169.16 M(+3.9%)
Mar 2014
-
-$10.73 M(-614.4%)
$162.75 M(-6.2%)
Dec 2013
$173.48 M(+8299.5%)
$2.09 M(-98.8%)
$173.48 M(+0.7%)
Sep 2013
-
$174.35 M(-6010.3%)
$172.28 M(<-9900.0%)
Jun 2013
-
-$2.95 M(<-9900.0%)
-$1.15 M(-190.8%)
Mar 2013
-
$0.00(-100.0%)
$1.27 M(-38.5%)
Dec 2012
$2.07 M(+12.0%)
$883.90 K(-3.3%)
$2.07 M(-9.0%)
Sep 2012
-
$913.70 K(-273.0%)
$2.27 M(+38.4%)
Jun 2012
-
-$528.10 K(-166.4%)
$1.64 M(-0.2%)
Mar 2012
-
$795.90 K(-26.9%)
$1.64 M(-10.9%)
Dec 2011
$1.84 M(-52.3%)
$1.09 M(+283.0%)
$1.84 M(-35.6%)
Sep 2011
-
$284.30 K(-154.2%)
$2.86 M(-33.0%)
Jun 2011
-
-$524.90 K(-152.7%)
$4.28 M(-10.7%)
Mar 2011
-
$996.20 K(-52.8%)
$4.79 M(+23.8%)
Dec 2010
$3.87 M(+97.5%)
$2.11 M(+24.3%)
$3.87 M(+56.0%)
Sep 2010
-
$1.70 M(<-9900.0%)
$2.48 M(+20.0%)
Jun 2010
-
-$14.10 K(-118.8%)
$2.06 M(-2.6%)
Mar 2010
-
$75.00 K(-89.6%)
$2.12 M(+8.3%)
Dec 2009
$1.96 M(-46.5%)
$720.30 K(-43.9%)
$1.96 M(+58.2%)
Sep 2009
-
$1.28 M(+2985.6%)
$1.24 M(-2796.5%)
Jun 2009
-
$41.60 K(-147.5%)
-$45.90 K(-47.5%)
Mar 2009
-
-$87.50 K
-$87.50 K
Dec 2008
$3.66 M(-91.8%)
-
-
Dec 2007
$44.65 M(+81.7%)
-
-
Dec 2006
$24.57 M(+7.3%)
-
-
Dec 2005
$22.90 M(+75.4%)
-
-
Dec 2004
$13.05 M(-664.1%)
-
-
Dec 2003
-$2.31 M(-110.2%)
-
-
Dec 2002
$22.65 M
-
-

FAQ

  • What is MorphoSys AG annual cash flow from financing activities?
  • What is the all time high annual CFF for MorphoSys AG?
  • What is MorphoSys AG annual CFF year-on-year change?
  • What is the all time high quarterly CFF for MorphoSys AG?
  • What is the all time high TTM CFF for MorphoSys AG?

What is MorphoSys AG annual cash flow from financing activities?

The current annual CFF of MOR is $46.55 M

What is the all time high annual CFF for MorphoSys AG?

MorphoSys AG all-time high annual cash flow from financing activities is $1.57 B

What is MorphoSys AG annual CFF year-on-year change?

Over the past year, MOR annual cash flow from financing activities has changed by -$281.87 M (-85.83%)

What is the all time high quarterly CFF for MorphoSys AG?

MorphoSys AG all-time high quarterly cash flow from financing activities is $1.52 B

What is the all time high TTM CFF for MorphoSys AG?

MorphoSys AG all-time high TTM cash flow from financing activities is $1.91 B